MEDICO, Enzo
 Distribuzione geografica
Continente #
NA - Nord America 9797
EU - Europa 4570
AS - Asia 2975
OC - Oceania 65
AF - Africa 39
SA - Sud America 35
Continente sconosciuto - Info sul continente non disponibili 20
Totale 17501
Nazione #
US - Stati Uniti d'America 9645
CN - Cina 2015
IT - Italia 1610
DE - Germania 574
GB - Regno Unito 330
FR - Francia 320
SE - Svezia 310
AT - Austria 285
UA - Ucraina 253
JP - Giappone 229
KR - Corea 216
FI - Finlandia 210
PL - Polonia 163
VN - Vietnam 154
CA - Canada 126
NL - Olanda 90
IN - India 86
DK - Danimarca 78
BE - Belgio 71
TW - Taiwan 67
AU - Australia 62
ES - Italia 58
CH - Svizzera 40
HK - Hong Kong 35
SG - Singapore 32
RO - Romania 29
TH - Thailandia 27
BR - Brasile 26
SN - Senegal 26
RU - Federazione Russa 25
MX - Messico 23
GR - Grecia 20
IE - Irlanda 18
EU - Europa 17
MY - Malesia 16
PT - Portogallo 16
TR - Turchia 16
ID - Indonesia 15
IR - Iran 15
NO - Norvegia 15
CZ - Repubblica Ceca 14
PK - Pakistan 10
PH - Filippine 9
HU - Ungheria 8
UZ - Uzbekistan 8
IL - Israele 7
BA - Bosnia-Erzegovina 5
CL - Cile 5
RS - Serbia 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
EG - Egitto 4
JO - Giordania 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
A1 - ???statistics.table.value.countryCode.A1??? 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
AL - Albania 2
AR - Argentina 2
BG - Bulgaria 2
CO - Colombia 2
DM - Dominica 2
HR - Croazia 2
KZ - Kazakistan 2
LT - Lituania 2
SI - Slovenia 2
AM - Armenia 1
BW - Botswana 1
CU - Cuba 1
GE - Georgia 1
GH - Ghana 1
IM - Isola di Man 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
NG - Nigeria 1
TZ - Tanzania 1
Totale 17501
Città #
Ann Arbor 2558
Fairfield 918
Beijing 767
Houston 733
Torino 477
Woodbridge 435
Ashburn 398
Chandler 396
Seattle 361
Wilmington 346
Cambridge 343
Dearborn 250
Vienna 246
Shanghai 230
Redwood City 214
Pisa 204
Villeurbanne 177
Jacksonville 166
Medford 163
Princeton 152
Warsaw 140
Guangzhou 130
Hangzhou 101
Dong Ket 89
Tokyo 82
Fremont 79
Nanjing 66
San Diego 64
Boston 61
Milan 58
Wuhan 58
Taipei 47
Shenyang 42
Nyköping 41
New York 37
Ottawa 36
Norwalk 35
Phoenix 35
Chengdu 34
Toronto 33
Nanchang 32
Zhengzhou 31
Brussels 29
Xian 29
Falls Church 27
Kunming 27
Rome 26
Verona 26
Buffalo 25
Changsha 25
Silver Spring 25
Munich 23
Seoul 23
Amsterdam 22
Fuzhou 22
Southend 22
Singapore 21
Hefei 20
Mountain View 20
Bangkok 19
Belfast 19
Jinan 18
Central District 17
Chongqing 17
Düsseldorf 16
Heidelberg 16
Rochester 15
London 14
Tianjin 14
Guiyang 13
Melbourne 13
Paris 13
Turin 13
Utrecht 13
Barcelona 12
Berlin 12
Changchun 12
Los Angeles 12
Nashville 12
Polska 12
Hebei 11
Pittsburgh 11
Harbin 10
Jakarta 10
Montréal 10
Nürnberg 10
San Mateo 10
Birmingham 9
Bologna 9
Duncan 9
Lachine 9
Mainz 9
Mexico 9
Padova 9
Philadelphia 9
Redmond 9
Zurich 9
Atlanta 8
Gurgaon 8
Leiden 8
Totale 11765
Nome #
Stromal contribution to the colorectal cancer transcriptome. 1458
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 603
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 595
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 546
Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer 489
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 442
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 428
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. 394
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 340
MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. 322
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 320
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 272
Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer 264
MicroRNA–mRNA interactions underlying colorectal cancer molecular subtypes 261
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 233
The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer. 214
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 202
Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. 194
Only a subset of Met-activated pathways are required to sustain oncogene addiction 188
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 186
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 185
Transcriptional hallmarks of noonan syndrome and noonan-like syndrome with loose anagen hair 181
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 176
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 176
Machine learning for RNA sequencing-based intrinsic subtyping of breast cancer 170
Met-driven invasive growth involves transcriptional regulation of Arhgap12 167
Analisi del profilo di trascrizione genetica nella sindrome di Noonan. 164
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 161
Evolving neoantigen profiles in colorectal cancers with DNA repair defects 161
Electrical conditioning of adipose-derived stem cells in a multi-chamber culture platform 161
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 160
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. 154
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 154
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 151
Exploiting orthologue diversity for systematic detection of gain-of-functionphenotypes 147
Inhibition of Src impairs the growth of met-addicted gastric tumors. 146
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 144
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature 143
Isolation and Characterization of a Spontaneously Immortalized Multipotent Mesenchymal Cell Line Derived from Mouse Subcutaneous Adipose Tissue 143
Mulcom: a multiple comparison statistical test for microarray data in Bioconductor 142
Sustained Met signalling in the heart leads to cardiac compensated hypertrophy and remodelling, which evolves into congestive heart failure 141
Detection of gene communities in multi-networks reveals cancer drivers 139
Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy 138
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin 137
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 135
Generation of Functional Hepatocytes from Mouse Germline Cell-derived Pluripotent Stem Cells in vitro 133
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 132
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 131
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart 125
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 120
A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells 120
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas 120
Semalytics: a semantic analytics platform for the exploration of distributed and heterogeneous cancer data in translational research 120
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 118
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers 115
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies 113
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. 112
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 112
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 109
Patient-derived xenografts (PDXs) as model systems for human cancer 109
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. 106
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 104
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 104
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 102
Formalin fixation at low temperature better preserves nucleic acid integrity. 100
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds 99
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 97
A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. 92
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 90
Reverse signaling by semaphorin 4C elicits SMAD1/5- And ID1/3-dependent invasive reprogramming in cancer cells 89
Transcriptional signature of Pseudomyxoma Peritonei: An enhancement of treatment strategy and outcome prediction 87
PDX-MI: Minimal information for patient-derived tumor xenograft models 86
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. 84
Gene expression profiling of HGF/Met activation in neonatal mouse heart 83
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 81
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 79
The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. 75
Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells 74
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib 73
Genome-wide analysis of unliganded estrogen receptor binding sites in breast cancer cells 71
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 71
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power 67
Biochemical and immunological properties of the human carcinoma antigen CAR-5 defined by the monoclonal antibody BD-5. 66
A gene trap vector system for identifying transcriptionally responsive genes 66
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 66
The c-met/HGF receptor in human tumours. 64
Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3. 64
Cancer and blood coagulation 64
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer 64
Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. 63
Structural and functional domains critical for constitutive activation of the HGF-receptor (Met). 62
Unveiling the pathogenetic role of Stat3 in human lymphoma 62
The MET oncogene drives a genetic programme linking cancer to haemostasis 61
Molecular anatomy of peripheral T cell lymphomas 59
The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. 55
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 54
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. 53
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle. 53
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 52
The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro 51
Totale 16609
Categoria #
all - tutte 22146
article - articoli 0
book - libri 0
conference - conferenze 2146
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181501 0000 092 146264 511262113113
2018/20192345 13187154134 90134 129245 118243566314
2019/20203554 248167216459 272606 348263 332294199150
2020/20213104 172191261188 218270 349173 266292196528
2021/20224807 488434415502 366335 428350 224217614434
2022/2023841 36329610280 00 00 0000
Totale 18030